CID 56644522

Poseltinib

Structural Information

Molecular Formula
C26H26N6O3
SMILES
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)OC=C4
InChI
InChI=1S/C26H26N6O3/c1-3-23(33)27-19-5-4-6-21(17-19)35-25-24-22(11-16-34-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)
InChIKey
LZMJNVRJMFMYQS-UHFFFAOYSA-N
Compound name
N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]furo[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

9
References

20829
Patents

470.20663 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 471.21391 213.1
[M+Na]+ 493.19585 218.4
[M-H]- 469.19935 222.0
[M+NH4]+ 488.24045 215.2
[M+K]+ 509.16979 212.1
[M+H-H2O]+ 453.20389 199.1
[M+HCOO]- 515.20483 228.6
[M+CH3COO]- 529.22048 219.5
[M+Na-2H]- 491.18130 214.8
[M]+ 470.20608 212.7
[M]- 470.20718 212.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe